Not Signed In - EU medical regulator recommends Novartis' bird flu vaccine
Sat, 24 Feb 2007 10:21 AM EST
... A European medical regulator has recommended marketing rights for Swiss drug maker Novartis AG's bird flu vaccine for humans. The Committee for Medicinal Products for Human Use, which reviews applications from drug makers for the 27-country bloc, has recommended to the European Commission approval for Novartis' Focetria as a vaccine in case of a pandemic flu caused by H5N1 avian flu virus. ...
Related Topics
- Avian Influenza
- Vaccine
- Vaccine Side Effects
- Bird flu (avian influenza)
- Drug and Medical Device Safety
- Understanding Medical Research
- Polio Vaccine & Cancer
- Medical Care
- Polio Vaccine
- Medical Errors
- Polio Vaccine & Origin of HIV/AIDS
- Medical Education & Training
- Influenza
- Emergency Medical Services
- Influenza (flu) Vaccine
- Flu Tests
- MMR Vaccine & (Asceptic) Meningitis
- Smallpox Vaccine
- Chickenpox Vaccine
- Hepatitis A Vaccine
email this page
print this page
bookmark this page
feedback on this page
